effects of glp 1 on appetite and weight How GLP-1 Weight-Loss Drugs Affect Appetite, Mood, Behavior GLP-1 for weight loss vs.
Description
thigh debate is everywhere but the right answer actually depends on which GLP-1 medication you're taking
In the STEP 3 randomised trial, once weekly semaglutide 2.4 mg used in obese adults without diabetes was associated with 4.9% incidence of gallbladder related disorders (mainly cholelithiasis) compared with 1.5% in the placebo group (1)
In REDEFINE 1, which enrolled 3,400 adults without diabetes but with at least one weight-related condition, CagriSema led to an average weight loss of 20.4% at Week 68 , compared to 14.9% with semaglutide, 11.5% with cagrilintide, and 3% with placebo
Check your benefits portal or contact HR
Under the expert guidance of our qualified healthcare professionals, your weight-loss journey will include evidence based strategies tailored specifically to your health status, medical history, and personal goals
